Editorial comment

J Urol. 2009 Oct;182(4):1317; discussion 1317. doi: 10.1016/j.juro.2009.06.153. Epub 2009 Aug 14.

Author

Arnulf Stenzl¹

Affiliation

¹ Department of Urology, University of Tuebingen, Tuebingen, Germany.

PMID: 19683279
DOI: 10.1016/j.juro.2009.06.153

No abstract available

Publication types

Comment

MeSH terms

Adjuvants, Immunologic / therapeutic use
Administration, Intravesical
Antibiotics, Antineoplastic / administration & dosage*
BCG Vaccine / therapeutic use
Combined Modality Therapy
Humans
Hyperthermia, Induced*
Mitomycin / administration & dosage*
Neoplasm Recurrence, Local / therapy*
Urinary Bladder Neoplasms / therapy*

Substances

Adjuvants, Immunologic
Antibiotics, Antineoplastic
BCG Vaccine
Mitomycin